DUBLIN--(BUSINESS WIRE)--The "Branded Generics Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type" report has been added to ResearchAndMarkets.com's offering.
This report describes the global market size of Branded Generics from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026.
For the geography segment, regional supply, demand, major players, price is presented from 2016 to 2026.
This report covers the following regions:
- North America
- South America
- Asia & Pacific
- Europe
- MEA
The key countries for each region are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
For the competitor segment, the report includes global key players of Branded Generics as well as some small players.
The information for each competitor includes:
- Company Profile
- Main Business Information
- SWOT Analysis
- Sales Volume, Revenue, Price and Gross Margin
- Market Share
Applications Segment:
- Oncology
- Cardiovascular Diseases
- Diabetes
- Neurology
- Gastrointestinal Diseases
Companies Covered:
- Mylan NV
- Novartis AG
- Eva Pharmaceutical Industries
- Pfizer
- Sun Pharmaceutical Industries
- Aspen Pharmacare Holding
- Abbott Laboratories
- Valeant Pharmaceuticals International
Key Topics Covered:
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 Covid-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Branded Generics Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Trading Analysis
8.1 Export of Branded Generics by Region
8.2 Import of Branded Generics by Region
8.3 Balance of Trade
Chapter 9 Historical and Forecast Branded Generics Market in North America (2016-2026)
9.1 Branded Generics Market Size
9.2 Branded Generics Demand by End Use
9.3 Competition by Players/Suppliers
9.4 Type Segmentation and Price
9.5 Key Countries Analysis
9.5.1 United States
9.5.2 Canada
9.5.3 Mexico
Chapter 10 Historical and Forecast Branded Generics Market in South America (2016-2026)
10.1 Branded Generics Market Size
10.2 Branded Generics Demand by End Use
10.3 Competition by Players/Suppliers
10.4 Type Segmentation and Price
10.5 Key Countries Analysis
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Chile
10.5.4 Peru
Chapter 11 Historical and Forecast Branded Generics Market in Asia & Pacific (2016-2026)
11.1 Branded Generics Market Size
11.2 Branded Generics Demand by End Use
11.3 Competition by Players/Suppliers
11.4 Type Segmentation and Price
11.5 Key Countries Analysis
11.5.1 China
11.5.2 India
11.5.3 Japan
11.5.4 South Korea
11.5.5 Southeast Asia
11.5.6 Australia
Chapter 12 Historical and Forecast Branded Generics Market in Europe (2016-2026)
12.1 Branded Generics Market Size
12.2 Branded Generics Demand by End Use
12.3 Competition by Players/Suppliers
12.4 Type Segmentation and Price
12.5 Key Countries Analysis
12.5.1 Germany
12.5.2 France
12.5.3 United Kingdom
12.5.4 Italy
12.5.5 Spain
12.5.6 Belgium
12.5.7 Netherlands
12.5.8 Austria
12.5.9 Poland
12.5.10 Russia
Chapter 13 Historical and Forecast Branded Generics Market in MEA (2016-2026)
13.1 Branded Generics Market Size
13.2 Branded Generics Demand by End Use
13.3 Competition by Players/Suppliers
13.4 Type Segmentation and Price
13.5 Key Countries Analysis
13.5.1 Egypt
13.5.2 Israel
13.5.3 South Africa
13.5.4 Gulf Cooperation Council Countries
13.5.5 Turkey
Chapter 14 Summary For Global Branded Generics Market (2016-2021)
14.1 Branded Generics Market Size
14.2 Branded Generics Demand by End Use
14.3 Competition by Players/Suppliers
14.4 Type Segmentation and Price
Chapter 15 Global Branded Generics Market Forecast (2021-2026)
15.1 Branded Generics Market Size Forecast
15.2 Branded Generics Demand Forecast
15.3 Competition by Players/Suppliers
15.4 Type Segmentation and Price Forecast
Chapter 16 Analysis of Global Key Vendors
For more information about this report visit https://www.researchandmarkets.com/r/jrxi98